ArticleProceedings of the National Academy of Sciences of the United States of America2008

Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1.

Alonso Heredia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.